G. Schwartz

发表

Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.

W. Enker, N. Kemeny, L. Saltz, 1993, International journal of radiation oncology, biology, physics.

Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial.

M. Socinski, S. Gettinger, D. Moore, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.

B. Teicher, A. Elias, L. Schnipper, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Shaun Parsons, E. Guinan, P. Mauch, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.

A. Elias, R. Gonin, C. Wheeler, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.

A. Elias, L. Schnipper, K. Antman, 1993, Journal of hematotherapy.

Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer.

J. Bertino, L. Saltz, D. Martin, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.

P. Richardson, B. Teicher, L. Schnipper, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols

A. Elias, L. Schnipper, K. Antman, 1991, Breast Cancer Research and Treatment.

Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.

A. Elias, R. Gonin, L. Schnipper, 1995, Bone marrow transplantation.

Intensive combined modality therapy for limited-stage small-cell lung cancer.

J. Eder, A. Elias, C. Wheeler, 1993, Journal of the National Cancer Institute.

High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer.

A. Elias, L. Schnipper, K. Antman, 1993, Chest.

A phase I/II trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head & neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT)

D. Brizel, T. Herman, D. Goffinet, 2001 .

Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation

G. Demetri, A. Elias, K. Antman, 1994, British journal of haematology.

High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity

A. Elias, K. Antman, C. Wheeler, 2004, Cancer Chemotherapy and Pharmacology.

Phase I/II trial of bevacizumab (B) and erlotinib (E) with induction (IND) and concurrent (CON) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic conformal radiotherapy (TCRT) in stage III non-small cell lung cancer (NSCLC).

M. Socinski, S. Gettinger, T. Stinchcombe, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer.

Yan Sun, Luc Y Dirix, Zefei Jiang, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

GM‐CSF mobilized peripheral blood stem cell autografts: The DFCI/BIH experience

A. Elias, L. Schnipper, K. Antman, 1992 .

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.

C. Lightdale, L. Saltz, D. Klimstra, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.

D. Fairclough, A. Elias, L. Schnipper, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.

G. Demetri, A. Elias, C. Wheeler, 1992, Blood.

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

M. Socinski, J. Beaumont, A. Peterman, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.

G. Schwartz, L. Saltz, P. Enzinger, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.

C. Shapiro, P. Richardson, A. Elias, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.

A. Elias, L. Schnipper, K. Antman, 1994, Seminars in Oncology.

The Role of Vitamin D in Normal Prostate Growth and Differentiation 1

Gary, R., Robert, 2005 .

Adjuvant chemotherapy in gastric adenocarcinomas.

G. Schwartz, D. Kelsen, F. Costa, 1998, Cancer treatment and research.